VEGFA and age-related macular degeneration: Thus, this study aimed at: (1) describing the polytherapy and multimorbidity pattern of users of anti-VEGF drugs for the treatment of age-related macular degeneration and other vascular retinopathies in clinical practice; (2) investigating the impact of polytherapy and multimorbidity on compliance, i.e., adherence to minimum requirements in terms of injections, examinations and follow-up duration.